Rachel Yehuda, PhD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Psychiatry, James J. Peters Veterans Affairs Medical Center, Bronx, New York

JCP
Ketamine Infusions and Written Exposure Therapy for Chronic PTSD
Original Research

April 2, 2025

Preliminary findings suggest that the combined treatment may yield large and durable symptom reductions for patients with severe chronic PTSD
, , , et al
JCP
Original Research

September 7, 2010

, , , et al
JCP
Original Research

April 13, 2010

, , , et al
JCP
Article

December 15, 2004

JCP
Article

January 1, 2004

, , , et al
JCP
Original Research

November 1, 2001

, , , et al
JCP
Article

January 3, 2001

Read an article about the biology of HPA Axis in posttraumatic stress disorder (PTSD) and reasoning for a reduction in cortisol levels in patients.
JCP
Article

January 3, 2001

JCP
Article

April 30, 2000

Read an article examining the biological alterations in posttraumatic stress disorder and the development progression of the neurobiology of this disorder.
PCC
Article

April 30, 2000

JCP
Article

June 1, 1999

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe